WuXi AppTec

History

Year	Detail
2000	The company was established.
2001	The company launched synthetic chemistry services.
2003	The company started manufacturing process development services.
2004	The company initiated manufacturing services for research and development.
2005	The company started bio-analytical services.
2007	The company was listed on the New York Stock Exchange.
2008	The company acquired AppTec Laboratory Services and was renamed as WuXi AppTec.
2011	The company acquired Medkey to expand clinical development and registration services.
2014	The company acquired XenoBiotic Laboratories to accelerate its research capabilities.
2015	The company was delisted from the New York Stock Exchange.
2017	The company acquired HD Biosciences to strengthen its biology R&D capacity and capabilities.
2018	The company was listed on the on Shanghai Exchange and Hong Kong Exchange.
2019	The company acquired Pharmapace to enhance biometrics services for clinical development.
2021	The company acquired OXGENE to strengthen further cell and gene therapy service offerings for global customers.